Advertisements



Pacific Biosciences" Sequel Sees Solid Q2, Competition Rife

Pacific Biosciences (P.....»»

Category: worldSource: nytAug 10th, 2018

Pacific Biosciences Gains as HudsonAlpha Picks Sequel System

Pacific Biosciences (PACB) sees increasing use of Sequel Sequencing System in pediatric and plant biologic case studies. Pacific Biosciences of Califo.....»»

Category: personnelSource: nytApr 12th, 2018

Pump the Brakes on the Illumina and Pacific Biosciences Deal

The United Kingdom's Competition and Markets Authority has opened an investigation into the acquisition. What happens now?.....»»

Category: topSource: foxnewsApr 20th, 2019

Pacific Biosciences Sequel installs could be light in Q1, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 13th, 2018

NuVasive"s (NUVA) Global Prospects Solid, Competition Rife

NuVasive (NUVA) demonstrates strong sales growth across all geographies. Competitive landscape is a concern. On Jun 4, we issued an updated research report on NuVasive, Inc. NUVA. We are upbeat.....»»

Category: personnelSource: nytJun 5th, 2018

Align Technology International Growth Solid, Rivalry Rife

Align Technology's (ALGN) Invisalign Technology prospects and growth in North America and outside hold great potential for the stock, particularly in the Asia-Pacific and EMEA regions. .....»»

Category: personnelSource: nytAug 23rd, 2018

Pacific Biosciences (PACB) Up as VGP Picks Flagship Sequel

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

Pacific Biosciences of California Stock Sees Short Interest Decline 13.5%

Market News Video.....»»

Category: topSource: redinewsSep 26th, 2018

Relative Strength Alert For Pacific Biosciences of California

Legendary investor Warren Buffett ad.....»»

Category: futuresSource: nasdaq9 hr. 3 min. ago

Despite Unexpected Competition From Jacobus, Catalyst Pharmaceuticals Still Has A Solid Business Model

Despite Unexpected Competition From Jacobus, Catalyst Pharmaceuticals Still Has A Solid Business Model.....»»

Category: topSource: seekingalphaMay 20th, 2019

ImmunoGen, Solid Biosciences and Insys lead Wednesday’s biotech losers

Shares of ImmunoGen Inc. led biotech’s losers on Wednesday, falling 38% in intraday trade after the company disclosed that the U.S. Food and Drug Administration had recommended it run a second Phase 3 trial of an ovarian cancer drug......»»

Category: topSource: marketwatchMay 15th, 2019

Texas Children"s Buys Enterprise Products Partners LP, Solid Biosciences Inc, ChemoCentryx Inc, ...

Related Stocks: EPD, SLDB, WVE, UTHR, GHDX, NBIX, CCXI, IOVA, AMRN, BCRX, AR,.....»»

Category: personnelSource: nytMay 14th, 2019

Why There May Be a Big Issue With This Duchenne Muscular Dystrophy Study

Solid Biosciences shares were crumbling on Tuesday after the firm announced its first-quarter results and an update to its midstage Duchenne muscular dystrophy trial......»»

Category: blogSource: 247wallstMay 14th, 2019

Solid Biosciences Tanks After Reporting Adverse Event In Duchenne Muscular Dystrophy Trial

The microcap biotech Solid Biosciences Inc (NASDAQ: SLDB)'s shares were losing m.....»»

Category: earningsSource: benzingaMay 14th, 2019

Solid Biosciences Tanks After Reporting Adverse Event In Duchenne Muscular Dystrophy Trial

The microcap biotech Solid.....»»

Category: blogSource: benzingaMay 14th, 2019

Mid-Day Market Update: Support.com Surges After Q1 Results; Solid Biosciences Shares Drop

Midway through trading Tuesday, the Dow traded up 0.76 percent to 25,518.63 while the NASDAQ climbed 0.91 percent to 7,716.42. The S&P also rose, gaining 0.78 percent to 2,833.93. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaMay 14th, 2019

The Daily Biotech Pulse: Further Delay in Roche"s Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings

Here's a roundup of .....»»

Category: earningsSource: benzingaMay 14th, 2019

Solid Biosciences downgraded to Neutral from Buy at Chardan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

Solid Biosciences downgraded to Underperform at Credit Suisse

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

Solid Biosciences downgraded to Sell from Neutral at Goldman Sachs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

The Daily Biotech Pulse: Further Delay in Roche"s Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 13) read more.....»»

Category: blogSource: benzingaMay 14th, 2019